Rights and permissions
About this article
Cite this article
Antibody therapy phase I trial safety remains topical. Inpharma Wkly. 1555, 2 (2006). https://doi.org/10.2165/00128413-200615550-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200615550-00002